Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.

Cancer Res Treat · 2017 · PMC5266402 · PMID 27188201

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Clinical parameters including female sex, young age, never smoker, well-differentiated cancer, and better performance status showed a trend toward a good response to treatment but were not statistically significant. 5.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.